Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans.
J. Clin. Invest. M H Rep, et al. 99:2225
doi:10.1172/JCI119396 [Go to this article.]

Problems with a PDF?